Shanghai Medicilon Inc.

¥74.38As of Sun 8 Nov 2026, 12:00 UTC
SSE:688202Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR 13.68%
Div yield —
ROE (2.24%)
Biotechnology
Beta (5Y) 0.90
PE TTM —
TSR TTM 5.65%
Mkt cap ¥9.784B
ROIC 0.51%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥71
(4.93%)
(31.83%)
Hold 9|0|6|12|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.82
0.81
0.85
0.90
7.52%
8.01%
4.57%
11.21%
Revenue¥M
497.2
507.7
515.3
503.3
2.19%
2.00%
3.83%
(0.02%)
Peers (US$1.467B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.557
0.128
0.113
EBIT/Intx
7.153
2.245
2.184
Own earn%
79.99
(29.64)
(32.67)
Sh yield%
33.97
23.21
24.77
Owners
Insiders/Inst%
6.06
70.73
Short interest%
2.74
SBC / revenue%
1.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
10–24
$1 testx
−0.3
Incr. ROIC%
6